PT  - JOURNAL ARTICLE
AU  - Champredon, David
AU  - Becker, Devan
AU  - Peterson, Shelley W.
AU  - Mejia, Edgard
AU  - Hizon, Nikho
AU  - Schertzer, Andrea
AU  - Djebli, Mohamed
AU  - Xie, Yuwei
AU  - Oloye, Femi F.
AU  - Asadi, Mohsen
AU  - Cantin, Jenna
AU  - Brinkmann, Markus
AU  - McPhedran, Kerry N.
AU  - Giesy, John P.
AU  - Mangat, Chand
TI  - Emergence and Spread of SARS-CoV-2 Variants of Concern in Canada: a Retrospective Analysis from Clinical and Wastewater Data
AID  - 10.1101/2022.12.09.22283256
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.12.09.22283256
4099  - http://medrxiv.org/content/early/2022/12/13/2022.12.09.22283256.short
4100  - http://medrxiv.org/content/early/2022/12/13/2022.12.09.22283256.full
AB  - The spread of SARS-CoV-2 has been studied at unprecedented levels worldwide. In jurisdictions where molecular analysis was performed on large scales, the emergence and competition of numerous SARS-CoV-2 lineages has been observed in near real-time. Lineage identification, traditionally performed from clinical samples, can also be determined by sampling wastewater from sewersheds serving populations of interest. Of particular interest are variants of concern (VOCs), SARS-CoV-2 lineages that are associated with increased transmissibility and/or severity. Here, we consider clinical and wastewater data sources to retrospectively assess the emergence and spread of different VOCs in Canada. We show that, overall, wastewater-based VOC identification provides similar in-sights to the surveillance based on clinical samples. Based on clinical data, we observed a synchrony in VOC introduction as well as similar emergence speeds across most Canadian provinces despite the large geographical size of the country and differences in provincial public health measures. In particular, it took approximately four months for VOC Alpha and Delta to contribute to half of the incidence, whereas VOC Omicron achieved the same contribution in less than one month. By quantifying the timing and rapidity of SARS-CoV-2 VOCs invasion in Canada, this study provides important benchmarks to support preparedness for future VOCs, and to some extent, for future pandemics caused by other pathogens.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe data from Saskatchewan was collected as part of the project titled "Next generation solutions to ensure healthy water resources for future generations" funded by the Global Water Futures program, Canada First Research Excellence Fund (\#419205; Additional information is available at www.globalwaterfutures.ca) and the Public Health Agency of Canada. Dr. Brinkmann is currently a faculty member of the Global Water Futures program. The authors acknowledge support of the City of Saskatoon Wastewater Treatment Plant. The research was supported by Discovery Grants from the Natural Science and Engineering Research Council of Canada awarded to Prof. Giesy and Dr. Brinkmann. The authors wish to acknowledge the support of an instrumentation grant from the Canada Foundation for Infrastructure. Prof. Giesy was supported by the Canada Research Chairs Program of the Natural Sciences and Engineering Research Council of Canada (NSERC) and a distinguished visiting professorship of Environmental Sciences from Baylor University in Waco, Texas, USA.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors